LianBio Income (Loss) Attributable to Parent, before Tax
LianBio (LIANY) reported Income (Loss) Attributable to Parent, before Tax of -$23.45 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToParent · last filed 2023-11-13
- LianBio income (loss) attributable to parent, before tax for the quarter ending 2023-09-30 was -$23.45M.
- LianBio income (loss) attributable to parent, before tax for the quarter ending 2023-06-30 was -$21.42M.
- LianBio income (loss) attributable to parent, before tax for the quarter ending 2023-03-31 was -$23.61M.
- LianBio income (loss) attributable to parent, before tax for the quarter ending 2022-12-31 was -$18.63M.
- LianBio income (loss) attributable to parent, before tax for fiscal 2022 was -$110.62M.
- LianBio income (loss) attributable to parent, before tax for fiscal 2021 was -$195.78M.
- LianBio income (loss) attributable to parent, before tax for fiscal 2020 was -$139.60M.
| Period end | Income (Loss) Attributable to Parent, before Tax 3 month | Income (Loss) Attributable to Parent, before Tax 6 month | Income (Loss) Attributable to Parent, before Tax 9 month | Income (Loss) Attributable to Parent, before Tax 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$23.45M 10-Q · filed 2023-11-13 | -$44.87M derived: sum of 2 quarters · filed 2023-11-13 | -$68.48M 10-Q · filed 2023-11-13 | -$87.11M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | -$21.42M 10-Q · filed 2023-08-14 | -$45.03M 10-Q · filed 2023-08-14 | -$63.65M derived: sum of 3 quarters · filed 2023-08-14 | -$85.55M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | -$23.61M 10-Q · filed 2023-05-11 | -$42.23M derived: sum of 2 quarters · filed 2023-05-11 | -$64.12M derived: sum of 3 quarters · filed 2023-11-13 | -$106.51M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | -$18.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$40.52M derived: sum of 2 quarters · filed 2023-11-13 | -$82.90M derived: sum of 3 quarters · filed 2023-11-13 | -$110.62M 10-K · filed 2023-03-28 |
| 2022-09-30 | -$21.89M 10-Q · filed 2023-11-13 | -$64.28M derived: sum of 2 quarters · filed 2023-11-13 | -$92.00M 10-Q · filed 2023-11-13 | -$114.23M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$42.39M 10-Q · filed 2023-08-14 | -$70.11M 10-Q · filed 2023-08-14 | -$92.34M derived: sum of 3 quarters · filed 2023-08-14 | -$105.84M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$27.72M 10-Q · filed 2023-05-11 | -$49.95M derived: sum of 2 quarters · filed 2023-05-11 | -$63.46M derived: sum of 3 quarters · filed 2023-05-11 | -$162.91M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$22.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$35.74M derived: sum of 2 quarters · filed 2023-03-28 | -$135.19M derived: sum of 3 quarters · filed 2023-03-28 | -$195.78M 10-K · filed 2023-03-28 |
| 2021-09-30 | -$13.51M 10-Q · filed 2022-11-10 | -$112.96M derived: sum of 2 quarters · filed 2022-11-10 | -$173.55M 10-Q · filed 2022-11-10 | -$186.29M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$99.45M 10-Q · filed 2022-08-11 | -$160.04M 10-Q · filed 2022-08-11 | -$172.78M derived: sum of 3 quarters · filed 2022-08-11 | -$293.02M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$60.59M 10-Q · filed 2022-05-12 | -$73.33M derived: sum of 2 quarters · filed 2022-05-12 | -$193.56M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$12.74M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | -$132.97M derived: sum of 2 quarters · filed 2022-03-31 | -$139.60M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$120.24M 10-Q/A · filed 2022-01-10 | -$126.86M 10-Q/A · filed 2022-01-10 |